文献速递白血病

成人急性淋巴细胞白血病中培门冬酶毒性的管理

How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia.
PubMed 文献 · Blood · 2020-01-01

本文针对成人急性淋巴细胞白血病(ALL)患者使用培门冬酶(pegasparaginase)时的独特毒性,通过真实病例阐述多数毒性为非致命、可管理且可逆的,并指导是否及如何继续用药。文章强调成人肿瘤科医生因不熟悉该药可能不愿使用或不必要地停药,从而错失多剂量培门冬酶的临床获益。

要点

  • 培门冬酶毒性独特,但多数为非致命、可管理且可逆。
  • 成人ALL采用儿童样方案时,多剂量培门冬酶的使用将增加。
  • 不应因可管理的毒性而不必要地停用培门冬酶,以免错失临床获益。

核心结论

  • 培门冬酶的多数毒性为非致命、可管理且可逆的,不应因毒性而常规停药。

研究设计与样本

  • 本文为基于真实病例的叙述性综述,描述接受含培门冬酶儿童样方案治疗的成人ALL患者的毒性管理。

主要发现

  • 培门冬酶的毒性特征独特,其他化疗药物未观察到类似毒性。
  • 成人肿瘤科医生可能因不熟悉或担心不良反应而停用培门冬酶,导致错失多剂量治疗的临床获益。

临床怎么用

  • 成人ALL患者使用培门冬酶时,应识别并管理其独特毒性,多数毒性可管理且可逆,无需常规停药。
  • 对于出现不良反应的成人ALL患者,应评估是否及如何继续培门冬酶治疗,而非不必要地停药。

局限性

  • 本文为叙述性综述,基于真实病例经验,未提供系统性的研究设计或样本量数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Administering asparaginase has always been problematic in adults because most general oncologists who treat adults are not familiar with its usage and toxicity. The toxicity profile of the drug is unique and is not observed with any other chemotherapy agent. Furthermore, asparaginase is almost exclusively used in acute lymphoblastic leukemia (ALL), which is a very rare cancer in adults. Currently, the long-acting pegylated form (pegasparaginase) is the only Escherichia coli-derived asparaginase available in the United States. The use of pediatric regimens is likely to lead to more adult patients receiving multiple doses of pegasparaginase. However, oncologists who treat adults may be reluctant to use pegasparaginase or may unnecessarily discontinue administering it because of certain adverse effects. As a result, the clinical benefit of multiple doses of pegasparaginase will be missed. Despite the fact that pegasparaginase is associated with unique toxicities, the majority are nonfatal, manageable, and reversible. Here, we describe real-life cases of adults with ALL who were treated with pediatric-inspired regimens that incorporated pegasparaginase to illustrate the management of several pegasparaginase-associated adverse effects and guide whether and how to continue the drug.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Aldoss I, Douer D. How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia. Blood. 2020. PMID: 31977001. doi:10.1182/blood.2019002477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。